trial · primary record
Neflamapimod
Moderate to Severe Acute Ischaemic Stroke
| Phase | Phase 2 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 45 |
| Primary completion | 2026-10-06 |
| Primary endpoint | Change from baseline to Week 12 in Fugl-Meyer Assessment of Motor Recovery after Stroke (FMMS) motor score (upper and lower) and total score |
| Registry ID | NCT06987643 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:38:26.824Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06987643
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.